( $ #$ $ 4.10 « ! " # # $ ! #$!%» : , ..- .., ... : &! ', ..- .., . . , , 2013. #!* $!%, $ # $ 2012 . ( !* – ! ! (78), # CHO $!%: • #!* 78 !$! • ! 3% #(" 9 78 • $ ! " 78 9 $!% 2013 : ~100 8* "* !$ #! pEGFP ( !* – ! ! 3 )!% — # ! ! !* ! " ! # +%/ $ ! #$!%. 2: • % ! #! !* !* 3 $ , ! 3 #(" • % $ $ ! #(" ! + ! /! # ! ! #(" " ! #("* – #" ! ! ! , !$ , !, #. 7!"* $+$/+ ! " "* - #" * $! ! (7, 7 .) !$ !* * > . : - $ $" 3# !% ! ! #. (, !) " (## , ) $+ ! ! " • !! • $ , !%% % -B) 2 * !$, # * C) ? * $/ 7 • $!%% • * !% "* ! ! $% & ('*): • • #% !%* #% "%* !$ !/ # $% #& & : ?* #* – +, ! ! $!$@ $" #9 (!*, 7!*) A% $+$/+ " # ! ! ( ): + -## D !%"* 7 9 0.53% Lipofectamine 2000 7 9 2.21% $!"* 7 9 23% ! #! !* ! $ D $ ! !%#!% ! 3# !% $ Ti:Sapphire ! ! ! 1048±2 ! ! 800 !!%% #$!% 115 !!%% #$!% 50 A* #$!% 40 9 A* #$!% 12 9 M 75 &?" M 80 &?" 1 – $ -# !, 2 – #!$!* #!, 3 – # ?!, 4 – !#, 5 – , 6,7 – !, 8 – 2 , 9 – !, 10 – $!% 3 #" ! !* * !$* #! !% !!% #!, 11 – !!-!* ! #, 12 – (, 13 – !, 14 – @ , 15 – , 16 – ! # !*, 17 – #!% #%/. & $ ! (" + ! ! !* " «» ! #!% # @ : # ! UD ! !* * 5050 ! 100100 D!$" !% @ ## !* ! #$ #(" # *!* !* " 3 ##" 536 617 !* " 9# #$ ! $ / ! #!%! !% !% !%" & 496 517 ( @ !* ! 3 #(" 9# ! 8* #("* ! ! (HO) , % / !## ! . %4 . A* #("* # # # $ ! #$!% " #$% 100 80 30 mW 36 mW 42 mW 48 mW 60 mW 60 40 1.3 20 0 0 50 100 150 200 450 500 , !* * 9# ! " #$% !9 #@% 2-3 1048±2 750 115 # 6 ! 50 ? 75 @ 0.94*10^12 6/^2 50 ' A 36 6 - 0.48 > A% #(" ! ! # #!% !$* ! / !## >% ! 100 100 80 80 60 60 40 40 20 20 0 0 0 20 40 60 80 100 " , % !,% B C ! ! 1048±2 !!%% #$!% 115 M 75 &?" * 3#" 10-100 A* #$!% 0.5 9 #$ 750 &( 100x, 1.3 NA Oil ** +% 36 % 10^12 / ^2 7!* !* &7 , +* 3% #(", .. !% #" $#@ @* 9# ! ! 17.5% # # !% # $ 3#" 40 A% #(" # #!% !$* # ! / !## ! D F 100 70%. 64%. 80 70 50%. 60 75%. 100 100 115 120-125 135 50 40 30 20 18%. 10 0 20 40 60 80 , 100 # !, % 90 90 80 70 80 60 50 60 40 30 40 20 10 5%. 20 20 40 60 80 100 , & !%* $#* 3% #(" (32%) ! ! * # !$ ! $ ! #$!% 3 1.4-1.5 9 (% 1.5-1.7*10^12 / ^2) 10-20 0 , % # !, % 100 A% #(" # #!% !$* # ! / !## ! D F 100 70%. 64%. 80 70 50%. 60 75%. 100 100 115 120-125 135 50 40 30 20 18%. 10 0 20 40 60 80 , 100 # !, % 90 90 80 70 80 60 50 60 40 30 40 20 10 5%. 20 20 40 60 80 100 , & !%* $#* 3% #(" (32%) ! ! * # !$ ! $ ! #$!% 3 40 1.4-1.5 20 9 (% 1.5-1.7*10^12 / ^2) 10-20 0 , % # !, % 100 A% #(" # #!% !$* # ! $ > % & ('*) # ! "! "&&" & 80 70 60 64%. 50 75%. 70%. 50%. 40 30 20 18%. 10 0 1 2 3 ' & (1- *, 2 - *, ) 5%. ! ! 800 !!%% #$!% 50 M 80 &?" * 3#" 20 A* #$!% 1.5 9 #$ 1.5 &( 60x, 0.9 NA Oil ** +% 120 % 1.58*10^12 / ^2 7!* !* &7 # !% * $# 3 #(" (32%) ! ! *!** 9 !$*. 2!/: % 2013 : ¾ -# (80 &?", 800 , 50, 1, 12 9) (75 &?", 1048 , 100 , 3 , 40 9) ! ! #! !* #* ! # ! $ ! ! ¾ # +%/ ! #! ! 3% $ ! !% ! ! "!%/ #(" ! + ! #! # !% !* #* #(" # ! !$* 9 !$*. ¾, # #!% !$* -# !, # !$ ! $ ! #$!% 3 1.4-1.5 9 10-20 * $#@* #("* !$" !* ! ! !, 60% !$. # #! ! ! !$!* * # # $! * " #$ # ! $!% * $ ! #$!% %/ @ #: 1.5 1012 / 2 ! "* #$!": D%: 1. .. !%, . . , . ., &.&. *, &. '. , Y.. Z , &.8. , “ $ ! #$!% " ! !*”// [8D27 \7Z [&[U, 2013, 51, ] 2, . 198–204. (I. V. Ilina, A. V. Ovchinnikov, D. S. Sitnikov, M. M. Rakityanskiy, M. B. Agranat, Y. V. Khramova, M. L. Semenova, “Application of Femtosecond Laser Pulses in Biomedical Cell Technologies”// High Temperature, 2013, Vol. 51, No. 2, pp. 173–178). 2. .. !%, .. , .. M, .. , &.'. , .. &!*, “'* $* ! # +%/ $ ! #$!% !* #(" ! +” // 7* A!, 43, ]4 (2013). 3. I.V. Ilina, A.V. Ovchinnikov, D.S. Sitnikov, O.V. Chefonov, M.B. Agranat, A.S. Mikaelyan, “Noncontact Microsurgery of Living Cell Membrane Using Femtosecond Laser Pulses,” Proc. SPIE 8803, Medical Laser Applications and Laser-Tissue Interactions VI, 88030A (2013). : 1. I.V. Ilina, A.V. Ovchinnikov, D.S. Sitnikov, O.V. Chefonov, M.B. Agranat, A.S. Mikaelyan, « Noncontact Microsurgery of Living Cell Membrane Using Femtosecond Laser Pulses» // &9$* "* «European Conference on Biomedical Optics 2013» (&/, ? *, 12.05 – 16.05.2012). 'D'E$ / 6F!